In addition, the hypomethylation status of the DNAH17 gene, both in tumor tissue and in adjacent non-cancerous tissue, could be a promising biomarker for tumor thrombosis in HCC. The gene discussed is DNAH17; the disease is hepatocellular carcinoma.